The Innovator Blog Series celebrates research conducted by 10x Genomics customers who have demonstrated scientific ingenuity by adapting Chromium Single Cell or Visium Spatial sequencing-based assays. These innovations are distinguished by their originality and potential impact on scientific discovery, including providing access to novel analytes, advancing multiomic analysis techniques, and demonstrating critical applications to human health and disease research. These techniques are customer developed, meaning they are not officially supported by 10x Genomics.
Why single cell for bacteria
Whatever your perception of bacteria may be, these tiny, squirming, ciliated buggers are, nonetheless, cells. They have a transcriptome, too, which can be measured (now, at the single cell level) to understand cellular identity and cell-to-cell heterogeneity.
Bacterial heterogeneity is a crucial matter of public health because of its relevance to antibiotic resistance. According to a 2019 global analysis of antimicrobial resistance, 1.27 million people died as a direct result of drug-resistant infections, far more than HIV/AIDS or malaria, which took 864,000 lives and 643,000 lives, respectively (1,2). As staggering as these numbers already are, some estimates project that by 2050, as many as ten million people could die each year because of antimicrobial resistance (2).
Bulk RNA sequencing is the most prevalent method to sequence the bacterial transcriptome; however, it can be easy to miss subtle cell-to-cell heterogeneity and rare cell subtypes as readouts from this method provide an average of gene expression in a sample. For this reason, characterizing bacterial cell heterogeneity and responses to antibiotics at the single cell level could be valuable in identifying persister populations and characterizing the underlying mechanisms of antibiotic resistance.
This motivated researchers from the Broad Institute of MIT and Harvard and from Massachusetts General Hospital to develop a method built on the Chromium Single Cell platform that enables highly scalable single cell analysis of bacterial cells. They used their technique, called BacDrop, to characterize Klebsiella pneumoniae clinical isolates and define the variable responses this population of bacteria has to different antibiotic treatments (3).
Keep reading to explore their innovative methods, which overcome a number of challenges to accessing mRNA in bacterial cells, and offer new insights into the role of mobile genetic elements in driving antibiotic resistance.
In-cell reactions solve the mRNA access problem
While eukaryotic cells have been tested and validated extensively on single cell sequencing platforms, prokaryotic cells (in this case, bacteria) don’t follow the eukaryotic norms. For example, one crucial difference between mammalian and bacterial cells is in the composition and accessibility of their messenger RNA (mRNA) molecules, or transcripts. These molecules carry the coding sequences for protein synthesis (4) and are quantified in gene expression profiling experiments.
Bacterial cells are also heavily dominated by ribosomal RNA (rRNA) and genomic DNA (gDNA). Accessing bacterial mRNA is also difficult because their cell walls require harsher lysis conditions than most eukaryotic cells, which risks damaging RNA integrity (3).
The solution to these two challenges go hand-in-hand. The research team from the Broad Institute developed a sample preparation method by which they fixed bacterial cells with formaldehyde—in essence freezing the cells and their contents—then permeabilized the cells with lysozyme (an enzyme that lyses bacterial cell membranes) while using RNase Inhibitor to maintain RNA integrity. After washing and resuspending the permeabilized cells, the team treated them with a series of enzyme solutions to perform in-cell bacterial rRNA and gDNA depletion (3).
Continuing their approach of performing reactions inside the fixed cells, the team developed a strategy to attach poly-A tails to bacterial mRNA. First, they plated cells in 384- or 96-well plates containing unique molecular identifier (UMI) sequences, round 1 plate barcodes to label cells, and a reverse transcription (RT) reaction solution. This reaction generated complementary DNA (cDNA) copies of all the mRNA molecules inside each bacterial cell with a plate-specific barcode.
Recovering and pooling the cells, the team then performed another in-cell reaction to “tail” cDNA molecules using terminal transferase, which involves the addition of deoxynucleotides to the 3' end of bacterial transcripts since they lack poly-A tails. Now, all cDNA molecules would have a poly-A tail, making it possible to perform second-strand cDNA synthesis using oligo-dT primers (a cDNA enrichment step that happens inside droplets on the Chromium platform), and subsequently to attach a round 2 droplet barcode to double-stranded cDNA. Using this approach, each unique cell would be identified by the combination of the round 1 plate barcode and round 2 droplet barcode, allowing researchers to load each droplet with multiple cells and, therefore, increase the throughput of the assay (3).
If you thought all of that was cool, here, the true wildcard of their experiment: the team prepared cells for droplet generation on the Chromium platform, but specifically using the Single Cell ATAC Library and Gel Bead Kit. This kit is technically designed to barcode DNA fragments from single nuclei. However, in this case, the researchers hacked it to capture cDNA fragments from single bacteria cells (pause, as your mind is blown). Using this high-throughput, microfluidics platform—including hundreds of thousands of unique droplet barcodes provided in the single cell ATAC kit—allowed the team to reduce plate-based combinatorial index steps and increase the efficiency and scale of their single cell analysis workflow.
After running bacterial cells through the assay, the team purified and enriched cDNA content, then constructed sequencing-ready libraries, completi